← All organizations

Centre Francais des Porphyries, Hopital Louis Mourier, Colombes, France

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 1, 2009

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

afamelanotide

Indications

Studied for

Protoporphyria, Erythropoietic

Recent trials (1)

NCT00979745Overall official - principal investigatorPhase 3Sep 1, 2009

Details

Last known activity: Sep 1, 2009